America’s biopharmaceutical research companies are developing 435 innovative new medicines to target 15 leading chronic conditions affecting the Medicare population, according to a new report released by the Pharmaceutical Research and Manufacturers of America last week.
The U.S. Global Research Program in May issued an 800-page National Climate Assessment report that does not bode well for the more than 50 million Americans with allergies and asthma — their already terrible symptoms are about to get worse.
With the ragweed season getting longer and longer, according to government reports, allergy has become a significant driver behind trips to the eye care aisle, and represents a much broader potential patient base. In response to rising temperatures, ragweed pollen season length increased between 1995 and 2011 by as much as 11 days (to 27 days) in parts of the United States and Canada.
Mylan on Wednesday announced the launch of risedronate sodium tablets USP, 150 mg. The drug is the generic version of Actonel tablets from Warner Chilcott and is used for the treatment of osteoporosis in post-menopausal women, according to the company.
Surrey, England-based Forme Laboratories, which specializes in menopause dermatology, has brought its Stratum C skin care line developed for peri-menopausal and menopausal skin to women in the United States.
Suppliers are given the opportunity to showcase their products for retail buyers at the GMDC Health, Beauty and Wellness Marketing Conference. Drug Store News highlights some of the hot beauty products in the showcase this year.
Suppliers are given the opportunity to showcase their products for retail buyers at the GMDC Health, Beauty and Wellness Marketing Conference. Below, Drug Store News highlights some of the hot OTC products in the showcase this year.
Looking to change sunscreen habits for those with darker skin tones, La Roche-Posay and the Women's Dermatologic Society have teamed up to take a stand by not just raising awareness, but encouraging true behavioral change through educating on two key motivators.
The American Academy of Pediatrics on Monday reported that many pregnant and breast-feeding women in the United States may be lacking iodine in their diets, which is an essential element for their babies’ brain development, according to a new policy statement, “Iodine Deficiency, Pollutant Chemicals, and the Thyroid: New Information on an Old Problem,” published in the June 2014 issue of Pediatrics.
Allergy season is at full strength, and it already seems to be one for the record books. Many patients are turning to their pharmacist to ask about the symptoms they are experiencing and why they feel so much worse than in years past. The answer — simple to some and hard to believe for others — is climate change.
With more women seeking advanced technology in their skin care regimen, beauty brand Philips is bringing its technology to the United States for the first time with the new Philips PureRadiance Facial Cleansing System.
In time for spring allergy season, Procter & Gamble has introduced Febreze Fabric Refresher Allergen Reducer, a product that eliminates odors and reduces up to 95% of inanimate allergens from pollen, pet dander and dust mite matter that can become airborne from fabrics after making their way into the home.
Bayer HealthCare on Monday announced that the Food and Drug Administration approved the company's new indication for Bayer's Kogenate FS antihemophilic factor VIII (recombinant) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.
The Food and Drug Administration on Thursday approved Zontivity (vorapaxar) tablets, an anti-platelet agent that's designed to decrease the tendency of platelets to clump together to form a blood clot.